cell mitochondria isolation buffer Search Results


90
Promega sv lysis buffer
Sv Lysis Buffer, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/sv+lysis+buffer/pmc03067138-229-6-14
Average 90 stars, based on 1 article reviews
sv lysis buffer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Promega rna lysis buffer
Rna Lysis Buffer, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/rna+lysis+buffer/us11072647-235-4-12
Average 90 stars, based on 1 article reviews
rna lysis buffer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphocyte isolation solution lymphoprep
Lymphocyte Isolation Solution Lymphoprep, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/lymphocyte+isolation+solution+lymphoprep/pm38664838-48-46-50
Average 90 stars, based on 1 article reviews
lymphocyte isolation solution lymphoprep - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Miltenyi Biotec isolation buffer provided in the mitochondria isolation kit miltenyi biotec 130 096 946
Isolation Buffer Provided In The Mitochondria Isolation Kit Miltenyi Biotec 130 096 946, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/Mitochondria+Isolation+Kit%2C+mouse+tissue/bio_rxiv__438739-160-28-36
Average 94 stars, based on 1 article reviews
isolation buffer provided in the mitochondria isolation kit miltenyi biotec 130 096 946 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

97
Miltenyi Biotec macs bsa stock solution
Macs Bsa Stock Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/MACS+BSA+Stock+Solution/pmc06245538-93-27-36
Average 97 stars, based on 1 article reviews
macs bsa stock solution - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

95
Valiant Co Ltd rnaprotm solution
Rnaprotm Solution, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/RNAPro+Solution/pm15569273-43-16-18
Average 95 stars, based on 1 article reviews
rnaprotm solution - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

99
ATCC cytotoxicity medium
Cytotoxicity Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/SJK-132-20/pmc03881531-192-36-30
Average 99 stars, based on 1 article reviews
cytotoxicity medium - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

97
Miltenyi Biotec fcr blocking reagent
Fcr Blocking Reagent, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/FcR+Blocking+Reagent%2C+mouse/10__1161_slash_circresaha__112__279109-300-12-16
Average 97 stars, based on 1 article reviews
fcr blocking reagent - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

90
Promega 1× cell lysis buffer
1× Cell Lysis Buffer, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/1x+lysis+buffer/pmc06993229-52-6-9
Average 90 stars, based on 1 article reviews
1× cell lysis buffer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Thermo Fisher pbs resuspended blood cell pellet
Pbs Resuspended Blood Cell Pellet, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/PBS/pm32373555-53-14-26
Average 99 stars, based on 1 article reviews
pbs resuspended blood cell pellet - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

97
Thermo Fisher mouse splenocytes
Adjuvant conditioning (AC) shapes the adaptive immune response in vivo . A: Experimental design. 8-10-week-old male or female C57BL/6 mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II <t>splenocytes</t> intravenously, and 24 hours after the transfer, mice were immunized subcutaneously with 10 μg OVA adsorbed in 1.5mg of Alum Imject™, in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Flow cytometry plots and total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. Flow cytometry plots and total number of OVA-specific Th1 (C) , Th2 (D) , Th17 (E) , and Tregs (F) , evidenced by the expression of CD4 + Vα + Tbet + , CD4 + Vα + GATA3 + , CD4 + Vα + RORγT + , and CD4 + Vα + Foxp3 + in splenocytes from mice treated with either saline or alum before the immunization. G: Flow cytometry plots and total number (H) of OVA-specific Th17 and Tregs, evidenced by the expression of CD4 + Vα + IL-17A and CD4 + Vα + LAP + in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. I: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.
Mouse Splenocytes, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/RBC+lysis+buffer+for+mouse/bio_rxiv__2024__09__06__611736-137-5-14
Average 97 stars, based on 1 article reviews
mouse splenocytes - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

99
Thermo Fisher cell culture supernatants
Adjuvant conditioning (AC) shapes the adaptive immune response in vivo . A: Experimental design. 8-10-week-old male or female C57BL/6 mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II <t>splenocytes</t> intravenously, and 24 hours after the transfer, mice were immunized subcutaneously with 10 μg OVA adsorbed in 1.5mg of Alum Imject™, in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Flow cytometry plots and total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. Flow cytometry plots and total number of OVA-specific Th1 (C) , Th2 (D) , Th17 (E) , and Tregs (F) , evidenced by the expression of CD4 + Vα + Tbet + , CD4 + Vα + GATA3 + , CD4 + Vα + RORγT + , and CD4 + Vα + Foxp3 + in splenocytes from mice treated with either saline or alum before the immunization. G: Flow cytometry plots and total number (H) of OVA-specific Th17 and Tregs, evidenced by the expression of CD4 + Vα + IL-17A and CD4 + Vα + LAP + in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. I: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.
Cell Culture Supernatants, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+mitochondria+isolation+buffer/RIPA+buffer/pm21364924-90-5-13
Average 99 stars, based on 1 article reviews
cell culture supernatants - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Adjuvant conditioning (AC) shapes the adaptive immune response in vivo . A: Experimental design. 8-10-week-old male or female C57BL/6 mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II splenocytes intravenously, and 24 hours after the transfer, mice were immunized subcutaneously with 10 μg OVA adsorbed in 1.5mg of Alum Imject™, in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Flow cytometry plots and total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. Flow cytometry plots and total number of OVA-specific Th1 (C) , Th2 (D) , Th17 (E) , and Tregs (F) , evidenced by the expression of CD4 + Vα + Tbet + , CD4 + Vα + GATA3 + , CD4 + Vα + RORγT + , and CD4 + Vα + Foxp3 + in splenocytes from mice treated with either saline or alum before the immunization. G: Flow cytometry plots and total number (H) of OVA-specific Th17 and Tregs, evidenced by the expression of CD4 + Vα + IL-17A and CD4 + Vα + LAP + in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. I: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: Adjuvant conditioning (AC) shapes the adaptive immune response in vivo . A: Experimental design. 8-10-week-old male or female C57BL/6 mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II splenocytes intravenously, and 24 hours after the transfer, mice were immunized subcutaneously with 10 μg OVA adsorbed in 1.5mg of Alum Imject™, in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Flow cytometry plots and total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. Flow cytometry plots and total number of OVA-specific Th1 (C) , Th2 (D) , Th17 (E) , and Tregs (F) , evidenced by the expression of CD4 + Vα + Tbet + , CD4 + Vα + GATA3 + , CD4 + Vα + RORγT + , and CD4 + Vα + Foxp3 + in splenocytes from mice treated with either saline or alum before the immunization. G: Flow cytometry plots and total number (H) of OVA-specific Th17 and Tregs, evidenced by the expression of CD4 + Vα + IL-17A and CD4 + Vα + LAP + in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. I: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Adjuvant, In Vivo, Injection, Saline, Flow Cytometry, Expressing, Cell Culture, In Vitro

NLRP3 activation required for the effects of adjuvant conditioning in the adaptive immune response. A . Experimental design. 8-10-week-old male or female C57BL/6 or NLRP3 -/- mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II splenocytes intravenously, and 24 hours after the transfer, mice were immunized with 10 μg OVA adsorbed in Resiquimod (R848) (OVA-RSQ) (50µg), in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. C: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. D: Flow cytometry plots of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. E: Total number of OVA-specific Th1, Th2, Th17 and Tregs, evidenced by the expression of CD4 + Vα + IFN-γ + , CD4 + Vα + IL-4 + , CD4 + Vα + IL-17A + and CD4 + Vα + LAP + respectively in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. Data shown represent three or more experiments, and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: NLRP3 activation required for the effects of adjuvant conditioning in the adaptive immune response. A . Experimental design. 8-10-week-old male or female C57BL/6 or NLRP3 -/- mice were injected intraperitoneally (i.p.) with either Alum Imject™ (8mg in 200µL) or saline three times, every other day. 24 hours after the last injection, mice were adoptively transferred with 5×10 6 OT-II splenocytes intravenously, and 24 hours after the transfer, mice were immunized with 10 μg OVA adsorbed in Resiquimod (R848) (OVA-RSQ) (50µg), in a homologous prime (day 1) and boost (day 8) protocol. Seven days after the boost (day 15), mice were euthanized, and spleens were analyzed for OVA-specific Th1, Th2, Th17, and Treg total numbers. B: Total number of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. C: OVA-specific IgG titer in serum from mice treated with either saline or alum before the immunization. D: Flow cytometry plots of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline or alum before the immunization. E: Total number of OVA-specific Th1, Th2, Th17 and Tregs, evidenced by the expression of CD4 + Vα + IFN-γ + , CD4 + Vα + IL-4 + , CD4 + Vα + IL-17A + and CD4 + Vα + LAP + respectively in splenocytes treated with either saline or alum before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. Data shown represent three or more experiments, and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Activation Assay, Adjuvant, Injection, Saline, Expressing, Flow Cytometry, Cell Culture, In Vitro

NLRP3-dependent IL-1 signaling is involved in the effects of adjuvant conditioning in the adaptive immune response. A: Flow cytometry plots and total number (B) of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline, alum or alum + Anakinra (30mg/kg) (AC + AK) before the immunization. C: OVA-specific IgG titer in serum from mice treated with either saline, alum or alum + Anakinra (30mg/kg) (AC+AK) before the immunization. D: Total number of OVA-specific Th1, Th2, Th17 and Tregs, evidenced by the expression of CD4 + Vα + IFN -γ + , CD4 + Vα + IL-4 + , CD4 + Vα + IL-17A + and CD4 + Vα + LAP + in splenocytes treated with either saline, alum or alum + Anakinra (30mg/kg) (AC+AK) before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. Data shown represent three or more experiments, and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: NLRP3-dependent IL-1 signaling is involved in the effects of adjuvant conditioning in the adaptive immune response. A: Flow cytometry plots and total number (B) of OVA-specific T cells, evidenced by the expression of CD4 + Vα + in splenocytes from mice treated with either saline, alum or alum + Anakinra (30mg/kg) (AC + AK) before the immunization. C: OVA-specific IgG titer in serum from mice treated with either saline, alum or alum + Anakinra (30mg/kg) (AC+AK) before the immunization. D: Total number of OVA-specific Th1, Th2, Th17 and Tregs, evidenced by the expression of CD4 + Vα + IFN -γ + , CD4 + Vα + IL-4 + , CD4 + Vα + IL-17A + and CD4 + Vα + LAP + in splenocytes treated with either saline, alum or alum + Anakinra (30mg/kg) (AC+AK) before the immunization and further cultured with OVAp (2μg/mL) in vitro for 48h in the presence of brefeldin-A. Data shown represent three or more experiments, and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Adjuvant, Flow Cytometry, Expressing, Saline, Cell Culture, In Vitro

Adjuvant conditioning induces the reprogramming of myeloid cells to a trained immunosuppression phenotype. A: Flow cytometry plots of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 24h after saline or alum injections. B: TNF-α, IL-6 (C) , IL-10 (D) , and nitric oxide (E) production from CD11b + GR1 + cells isolated from saline or AC-treated mice cultured with either medium or LPS (200ng/mL) for 24h. F: Histograms of CD4 + Vα + cells in a suppression assay using isolated CD11b + GR1 + cells. Isolated MDSCs from spleens from AC-treated mice were cultured with OVAp (1µg/mL), C57BL/6 splenocytes (1×10 5 ) and isolated OT-II naïve CD4 T cells (2×10 5 ) in the ratios (MDSC : T cell) indicated in the graph. G: Percentage of CD4 + Vα + CTV low cells in a suppression assay using isolated CD11b + GR1 + cells and OT-II CD4 T cells. H: Percentage of CD4 + Vα + FVD + cells in a suppression assay using isolated CD11b + GR1 + cells and OT-II CD4 T cells. I: Flow cytometry plots of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 1 day, 7 days, and 14 days after saline or alum injections. J: Total count of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 1 day, 7 days, and 14 days after saline or alum injections. K: TNF-α, and nitric oxide (L) production from CD11b + GR1 + cells isolated 1 day, 7 days, and 14 days after saline or alum injections cultured with either medium or LPS (200ng/mL) for 24h. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: Adjuvant conditioning induces the reprogramming of myeloid cells to a trained immunosuppression phenotype. A: Flow cytometry plots of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 24h after saline or alum injections. B: TNF-α, IL-6 (C) , IL-10 (D) , and nitric oxide (E) production from CD11b + GR1 + cells isolated from saline or AC-treated mice cultured with either medium or LPS (200ng/mL) for 24h. F: Histograms of CD4 + Vα + cells in a suppression assay using isolated CD11b + GR1 + cells. Isolated MDSCs from spleens from AC-treated mice were cultured with OVAp (1µg/mL), C57BL/6 splenocytes (1×10 5 ) and isolated OT-II naïve CD4 T cells (2×10 5 ) in the ratios (MDSC : T cell) indicated in the graph. G: Percentage of CD4 + Vα + CTV low cells in a suppression assay using isolated CD11b + GR1 + cells and OT-II CD4 T cells. H: Percentage of CD4 + Vα + FVD + cells in a suppression assay using isolated CD11b + GR1 + cells and OT-II CD4 T cells. I: Flow cytometry plots of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 1 day, 7 days, and 14 days after saline or alum injections. J: Total count of CD11b + Ly6C + and CD11b + Ly6G + cells in the spleen 1 day, 7 days, and 14 days after saline or alum injections. K: TNF-α, and nitric oxide (L) production from CD11b + GR1 + cells isolated 1 day, 7 days, and 14 days after saline or alum injections cultured with either medium or LPS (200ng/mL) for 24h. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Adjuvant, Flow Cytometry, Saline, Isolation, Cell Culture, Suppression Assay

AC-induced MDSCs inhibition of the adaptive immune response in vivo requires NLRP3 activation and IL-1 signaling. A: Experimental design. Briefly, 2×10 6 CD11b + GR1 + cells isolated from either AC, alum + Anakinra (30mg/kg) (AC+AK) or saline-injected C57BL/6 or NLRP3 -/- mice were adoptively transferred to C57BL/6 mice before the immunization protocol. B: Flow cytometry plots and total number of OVA-specific T cells (C) , evidenced by the expression of CD4 + Vα + in splenocytes from mice adoptively transferred with CD11b + GR1 + cells isolated from either AC, or saline-injected C57BL/6 before the immunization protocol. D: OVA-specific IgG titer in serum from mice adoptively transferred with CD11b + GR1 + cells isolated from either AC, or saline-injected C57BL/6 before the immunization protocol. E: Flow cytometry plots and total number of OVA-specific T cells (F) , evidenced by the expression of CD4 + Vα + in splenocytes from mice adoptively transferred with CD11b + GR1 + cells isolated from either alum + Anakinra (30mg/kg) (AC+AK) or saline-injected C57BL/6 or NLRP3 -/- mice before the immunization protocol. G: OVA-specific IgG titer in serum from mice adoptively transferred with CD11b + GR1 + cells isolated from either alum + Anakinra (30mg/kg) (AC + AK) or saline-injected C57BL/6 or NLRP3 -/- mice before the immunization protocol. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: AC-induced MDSCs inhibition of the adaptive immune response in vivo requires NLRP3 activation and IL-1 signaling. A: Experimental design. Briefly, 2×10 6 CD11b + GR1 + cells isolated from either AC, alum + Anakinra (30mg/kg) (AC+AK) or saline-injected C57BL/6 or NLRP3 -/- mice were adoptively transferred to C57BL/6 mice before the immunization protocol. B: Flow cytometry plots and total number of OVA-specific T cells (C) , evidenced by the expression of CD4 + Vα + in splenocytes from mice adoptively transferred with CD11b + GR1 + cells isolated from either AC, or saline-injected C57BL/6 before the immunization protocol. D: OVA-specific IgG titer in serum from mice adoptively transferred with CD11b + GR1 + cells isolated from either AC, or saline-injected C57BL/6 before the immunization protocol. E: Flow cytometry plots and total number of OVA-specific T cells (F) , evidenced by the expression of CD4 + Vα + in splenocytes from mice adoptively transferred with CD11b + GR1 + cells isolated from either alum + Anakinra (30mg/kg) (AC+AK) or saline-injected C57BL/6 or NLRP3 -/- mice before the immunization protocol. G: OVA-specific IgG titer in serum from mice adoptively transferred with CD11b + GR1 + cells isolated from either alum + Anakinra (30mg/kg) (AC + AK) or saline-injected C57BL/6 or NLRP3 -/- mice before the immunization protocol. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in the graphs. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Inhibition, In Vivo, Activation Assay, Isolation, Saline, Injection, Flow Cytometry, Expressing

Adjuvant conditioning promotes allogeneic tolerance dependent on NLRP3. A: Allogeneic pancreatic islet transplantation experimental design. Briefly, alum or saline-treated C57BL/6 or NLRP3 -/- mice were treated with streptozotocin (STZ) 4 days before the transplantation with Balb/c isolated pancreatic islets. Survival of the graft was assessed daily by checking blood glucose levels. B: Survival curve of alum or saline-treated C57BL/6 or NLRP3 -/- mice that underwent allogeneic pancreatic islet transplantation. C57BL/6 saline (n=5), AC (n=6), NLRP3 -/- saline (n=5), AC (n=6). Graft survival significance was assessed by Kaplan-Meier/Mantel-Cox log-rank test. C: Cutaneous hypersensitivity experimental design. Briefly, alum or saline-treated C57BL/6 or NLRP3 -/- mice were subcutaneously immunized with 20× 10 6 Balb/c splenocytes on the neck. Seven days later, mice were challenged with 20×10 6 Balb/c splenocytes injected subcutaneously into the base of the ear, as described by . D: Cutaneous allogeneic response was assessed by measuring ear pinna swelling (mm) at 2-, 4- and 24- hours post-challenge. P-values show the comparison between ear swelling at 24-hours post-challenge. n=10 for each group. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Journal: bioRxiv

Article Title: Adjuvant conditioning shapes the adaptive immune response and promotes trained immunotolerance via NLRP3/IL-1

doi: 10.1101/2024.09.06.611736

Figure Lengend Snippet: Adjuvant conditioning promotes allogeneic tolerance dependent on NLRP3. A: Allogeneic pancreatic islet transplantation experimental design. Briefly, alum or saline-treated C57BL/6 or NLRP3 -/- mice were treated with streptozotocin (STZ) 4 days before the transplantation with Balb/c isolated pancreatic islets. Survival of the graft was assessed daily by checking blood glucose levels. B: Survival curve of alum or saline-treated C57BL/6 or NLRP3 -/- mice that underwent allogeneic pancreatic islet transplantation. C57BL/6 saline (n=5), AC (n=6), NLRP3 -/- saline (n=5), AC (n=6). Graft survival significance was assessed by Kaplan-Meier/Mantel-Cox log-rank test. C: Cutaneous hypersensitivity experimental design. Briefly, alum or saline-treated C57BL/6 or NLRP3 -/- mice were subcutaneously immunized with 20× 10 6 Balb/c splenocytes on the neck. Seven days later, mice were challenged with 20×10 6 Balb/c splenocytes injected subcutaneously into the base of the ear, as described by . D: Cutaneous allogeneic response was assessed by measuring ear pinna swelling (mm) at 2-, 4- and 24- hours post-challenge. P-values show the comparison between ear swelling at 24-hours post-challenge. n=10 for each group. Data shown represent three or more experiments and are expressed as mean±SEM; Student t-test was used for analysis; P values are indicated in each graph. All statistical analyses were performed using GraphPad Prism™.

Article Snippet: Single-cell suspensions were prepared from mouse splenocytes after RBC lysis using ACK lysis buffer (ThermoFisher Scientific).

Techniques: Adjuvant, Transplantation Assay, Saline, Isolation, Injection, Comparison